Asuragen is a fully integrated diagnostics company focused on molecular oncology and early detection of cancer, with an emphasis on microRNA. Asuragen's current diagnostics product portfolio consists of Signature® Genetic and Oncology Testing products, as well as industry leading controls and standards engineered using its patented Armored RNA® technology. In addition to its diagnostics products, Asuragen offers GLP testing services and an established cGMP manufacturing facility that allow it to span the spectrum of discovery, testing, production and commercialization.

Ionis Pharmaceuticals, Inc. engages in the development and commercialization of human therapeutic drugs using antisense technology. It operates through the Ionis Core segment. The Ionis Core segment exploits a novel drug discovery platform to generate a pipeline of drugs. The company was founded by Stanley T. Crooke, David J. Ecker, Christopher K. Mirabelli, and Brett P. Monia in 1989 and is headquartered in Carlsbad, CA.

Yissum is the technology transfer company of The Hebrew University of Jerusalem. Founded in 1964, it is the 3rd company of its kind ever created, and has a rich tradition of innovation and commercialization. Through our efforts to identify and create breakthrough scientific research at Hebrew University, we aspire to advance commercial solutions to the most pressing global challenges facing humanity. (Contact Tamir Huberman) Some of our well-known spin-off companies include Mobileye, Orcam, Collplant, Qlight, and Briefcam. Yissum’s business partners span the globe and include companies such as Novartis, Johnson & Johnson, Merck, Intel, Google, Boston Scientific, ICL and many more. Since its inception, Yissum has registered 10,000+ patents covering 2,800+ inventions; licensed 900 technologies and produced 130+ spin-off companies.

Beijing Huarui Kangyuan Biotechnology Development Co., Ltd., established on 2017-10-19, The business scope includes the sale of third-class medical devices;production first class,second category,Class III medical devices;biological reagent,medical instruments,software technology development,technical consulting,Technical Services,technology transfer;software development;Computer System Services;SalesIkind,IIclass of medical devices,computer software,Hardware and Auxiliary Equipment,Equipment,Instrumentation,Chemical Products(Free of Hazardous Chemicals),Wujinjiaodian;Mechanical and electrical equipment rental;Natural science research and experimental development;Engineering and Technology Research and Experimental Development;Medical Research and Experimental Development;Import and export,Agent import and export,Technology Import and Export;Technical testing.(Market entities independently choose business projects in accordance with the law,Carry out business activities;Items subject to approval by law,Carry out business activities in accordance with the approved content after approval by relevant departments;Do not engage in the business activities of projects prohibited and restricted by the industrial policies of the state and this city.)

Design Therapeutics is a biotechnology company developing a new class of therapies for serious degenerative disorders caused by nucleotide repeat expansions. The company’s lead program is focused on the treatment of Friedreich’s ataxia and discovery efforts are ongoing in other degenerative diseases.

The University of California is the nation's best public university system, delivering top-notch research and innovation to California (and the world).

Shanghai Five-color Stone Medical Research Co., Ltd., established on 2013-01-23, The scope of business includes engaging in medical technology,Biological Technology,Technology development in the field of molecular diagnostic technology,technical consulting,Technical Services,technology transfer,Chemical raw materials and products(Removal of hazardous chemicals,Monitor Chemicals,precursor chemicals,firecrackers)laboratory equipment,Computer software and auxiliary equipment,Sales of office equipment,Engaged in the import and export of goods and technology,Medical device production(See the license for specific business scope),Medical Device Sales. [Items subject to approval by law,Business activities can only be carried out after approval by relevant departments]

Novartis AG is a holding company, which engages in the development, manufacture, and marketing of healthcare products. It operates through the following segments: Innovative Medicines, Sandoz, and Corporate. The Innovative Medicines segment researches, develops, manufactures, distributes and sells patented pharmaceuticals, and is composed of two business units: Novartis Oncology and Novartis Pharmaceuticals. The Sandoz segment develops, manufactures and markets finished dosage form medicines as well as intermediary products, including active pharmaceutical ingredients. The Corporate segment refers to group management and central services. The company was founded on February 29, 1996 and is headquartered in Basel, Switzerland.

Regents of The University of Michigan provides administers bonds on behalf of the University. The company is headquartered in Ann Arbor, MI.

Fulcrum Therapeutics is a biotechnology company that develops new medicines to treat patients with rare genetic diseases. The company develops a proprietary product engine that is employed to identify and validate cellular drug targets that can modulate gene expression. Its product candidate, losmapimod, is a small molecule that was developed for the treatment of FSHD, a muscle-wasting disorder that leads to physical impairment and disability. It is focused on improving the lives of patients with genetically defined diseases in areas of high unmet medical need, with an initial focus on rare diseases. Founded in 2016, the company is based in Cambridge, Massachusetts, United States.

Forge Biologics, Inc. operates as a gene therapy development engine, focused on enabling access to life changing gene therapies. The firm is a viral vector gene therapy manufacturing and development company with the dual platform of CDMO capabilities and the development of proprietary gene therapy products. The company was founded by Timothy J. Miller and Jaysson Eicholtz and is headquartered in Columbus, OH.

Massachusetts General Hospital was established to provide care to Boston's sick, regardless of socioeconomic status—an innovative idea in 1811. In the words of their founder, John Warren, MD, “When in distress, every man becomes their neighbor.” They subsequently became the first teaching hospital for Harvard University’s new medical school and have been redefining excellence in healthcare ever since. They have remained at the forefront of medicine by fostering a culture of collaboration, pushing the boundaries of medical research, educating the brightest medical minds and maintaining an unwavering commitment to the diverse community they were created to serve. They believe that because of diversity they excel, through inclusion they respect their community, and with a keen focus on equity they serve, heal, educate and innovate at the highest levels. Their first priority is the well-being of their patients—near and far. As a team they are able to maintain a singular focus on providing the highest quality, most compassionate care to each and every patient.

Xiamen Baiouxun Biotechnology Co., Ltd., established on 2019-01-10, Business scope includes general items:Technology promotion and application services;Sales of Class II Medical Devices;Sales of Class I Medical Devices;Production of Class I Medical Devices.(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license).licensed items:pharmaceutical production;Class III medical device business;Production of Class II Medical Devices;Production of Class III Medical Devices;Technology Import and Export;Import and export.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,The specific business items are subject to the approval documents or licenses of relevant departments).

Shanghai Baizhen Biotechnology Co., Ltd., established on 2009-10-14, The business scope includes R&D and sales of instruments and meters;Technology development within the specialized field of biotechnology,technology transfer,technical consulting,Technical Services,Engaged in the import and export of goods and technology,Electromechanical equipment and accessories,Sales of electronic appliances,Expo Services;Wholesale of food(non-physical means,Limited to branch operations). [Items subject to approval by law,Business activities can only be carried out after approval by relevant departments]

CoWin Biosciences (CWBIO) provides high-quality biology reagents in life science research and molecular diagnostics field. They have developed more than 1000 products for Nucleic Acid Extraction & Purfication, PCR, Real-time PCR, Markers, Library Preparation for Next Generation Sequencing, Sample Perservative, Molecular Diagnostics and Protein Assays. CWBIO was founded in 2007 with the total investment of more than of 10 million US dollars. With advanced instruments and facilities, workshops which were fully in line with national GMP standards and international manufacture technology applied to all the products. In 2014, they have been certified to ISO9001:2008 and ISO13485:2003 quality standards. Their products are used by thousands of scientists around the world and cited in more than 1,000 peer-reviewed publications.

Guangzhou Yuanguji Technology Co., Ltd., established on 2019-05-20, Business scope includes medical technology transfer services;Medical Technology Consulting,communication service;Internet commodity retail(Except for licensed and approved products);computer hardware research,to develop;E-commerce information consultation;Data Processing and Storage Services;Technical Services(Does not include license approval items);translation service;Information system integration service;Computer Network System Engineering Services;Research on Network Technology,to develop;Information Technology Consulting Services;Conference and Exhibition Services;Biotechnology Consulting,communication service;Network information technology promotion service;Medical technology promotion service;Medical technology research and development;Electronics retail;Commodity wholesale trade(Except for licensed and approved products);Commodity retail trade(Except for licensed and approved products);Gene drug development;Biomedical Technology Research;Wholesale of computer spare parts;Medical Equipment Repair;for medical devices,equipment,Professional cleaning of medical and sanitary materials and supplies,Disinfection and Sterilization;Operation of non-licensed medical devices;Medical supplies and equipment retail(Does not contain drugs and medical devices);Medical equipment rental service;Counseling Services(Does not include medical counseling,Medical Psychological Training,Medical psychological counseling and other medical behaviors);the medical,Medical Consulting Services(Does not involve a medical diagnosis,Treatment and Rehabilitation Services);medical diagnosis,Monitoring and treatment equipment wholesale;Licensed medical device business;medical diagnosis,Monitoring and treatment equipment retail

The Board of Regents of The University of Texas System, a subsidiary of The University of Texas at Austin, is an American company located in Austin, TX. The firm oversees college activities.

Shenzhen Huizhong Biotechnology Co., Ltd., established on 2017-10-26, Business scope includes general business items:Biotechnology Consulting,technology development,technology transfer,Technical Services;medical technology development;Technical development of in vitro diagnostic reagents,Technical service and sales;Technical development of inspection and analysis instruments;Import and export of goods and technology.,The licensing program is:Sales of Medical Devices.